Optiray (Ioversol)

Optiray (ioversol) is used as an iodinated contrast agent in diagnostic imaging procedures.

• Angiography: provides high‑contrast visualization of arterial and venous structures.
• Computed tomography (CT) imaging: enhances tissue differentiation and lesion detection.
• Urography: improves delineation of the urinary tract and renal collecting system.
• Cerebral angiography: facilitates detailed imaging of cerebral vasculature.
• Cardiac catheterization: aids visualization of coronary arteries and cardiac chambers.

• Ioversol contains multiple iodine atoms that strongly absorb X‑ray photons. When injected into the vascular system, the iodine increases the radiodensity of blood and surrounding tissues, creating a contrast between structures on X‑ray‑based imaging modalities such as CT, angiography, and fluoroscopy, thereby improving diagnostic detail.

Adverse reactions may occur following administration of Optiray.

Common Side Effects

• Warm sensation or flushing at the injection site
• Metallic taste in the mouth
• Nausea or mild vomiting
• Headache
• Transient urticaria or skin redness
• Mild dizziness

Serious or Rare Side Effects

• Anaphylactic or severe allergic reaction
• Acute renal impairment or contrast‑induced nephropathy
• Hypotension or cardiovascular collapse
• Cardiac arrhythmias
• Seizures or neurologic disturbances
• Pulmonary edema or respiratory distress

Prior to using Optiray, clinicians should consider several safety measures.

• Renal function assessment: evaluate serum creatinine and eGFR before injection.
• Allergy history: screen for prior reactions to iodinated contrast or iodine‑containing substances.
• Dose minimisation: use the lowest volume required for adequate imaging.
• Vital sign monitoring: observe blood pressure and heart rate during and after administration.
• Contra‑indication review: avoid in patients with known severe iodine hypersensitivity.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Optiray may interact with other agents that affect renal function or allergic response.

Major Interactions (Avoid)

• Concurrent iodinated contrast agents: cumulative iodine load can increase toxicity.
• Nephrotoxic drugs (e.g., aminoglycosides, high‑dose NSAIDs): heighten risk of renal injury.
• High‑dose corticosteroids: may mask early signs of an allergic reaction.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may alter hemodynamic response during contrast injection.
• Diuretics: can affect renal clearance of iodine.
• ACE inhibitors or ARBs: may increase susceptibility to contrast‑induced nephropathy.
• Anticoagulants: monitor bleeding risk if invasive imaging is performed.
• Thyroid medications: excess iodine may interfere with thyroid hormone regulation.